AI-generated summary
The authors report a placebo-controlled, double blind, cross-over study of 80 volunteers in which a low energy Er:YAG laser was used to ablate upper-arm skin before a 5-minute lidocaine or placebo application. Combined lidocaine preparations produced a statistically significant reduction in needle insertion pain compared with placebo when the laser device was used, with a median pain reduction of 51.3%.
- Participants
- 80
- Who or what was studied
- Adult volunteers (upper-arm skin, needle insertion)
- Limits stated in the abstract
- The abstract does not describe limitations, and the study examined only immediate pain scores following a single needle insertion.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.